JR Rahn is the founder of MindMed. MindMed has raised $204M in total funding. Latest round: IPO. Based in Miami, Florida.
JR Rahn is the co-founder and former CEO of MindMed, the first publicly listed psychedelic medicine biotech company. He oversaw the raising of $204 million in capital before stepping down as CEO in June 2021. He currently serves as a board member and shareholder of MindMed while maintaining his role as co-founder.
Full founder directory · Investor directory · Company funding database · Fundraising library